- Home
- VERO vs QNRX Comparison
VERO vs QNRX Comparison
Compare VERO & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERO
- QNRX
- Stock Information
- Founded
- VERO N/A
- QNRX 2018
- Country
- VERO Canada
- QNRX United States
- Employees
- VERO N/A
- QNRX N/A
- Industry
- VERO Medical/Dental Instruments
- QNRX Medical/Dental Instruments
- Sector
- VERO Health Care
- QNRX Health Care
- Exchange
- VERO Nasdaq
- QNRX Nasdaq
- Market Cap
- VERO 2.4M
- QNRX 2.7M
- IPO Year
- VERO N/A
- QNRX N/A
- Fundamental
- Price
- VERO $0.31
- QNRX $0.32
- Analyst Decision
- VERO
- QNRX Strong Buy
- Analyst Count
- VERO 0
- QNRX 1
- Target Price
- VERO N/A
- QNRX $4.00
- AVG Volume (30 Days)
- VERO 128.1K
- QNRX 4.1M
- Earning Date
- VERO 03-31-2025
- QNRX 03-12-2025
- Dividend Yield
- VERO N/A
- QNRX N/A
- EPS Growth
- VERO N/A
- QNRX N/A
- EPS
- VERO N/A
- QNRX N/A
- Revenue
- VERO $67,200,000.00
- QNRX N/A
- Revenue This Year
- VERO N/A
- QNRX N/A
- Revenue Next Year
- VERO $4.95
- QNRX N/A
- P/E Ratio
- VERO N/A
- QNRX N/A
- Revenue Growth
- VERO N/A
- QNRX N/A
- 52 Week Low
- VERO $0.28
- QNRX $0.28
- 52 Week High
- VERO $1.59
- QNRX $6.18
- Technical
- Relative Strength Index (RSI)
- VERO 38.70
- QNRX 38.39
- Support Level
- VERO $0.30
- QNRX $0.30
- Resistance Level
- VERO $0.32
- QNRX $0.35
- Average True Range (ATR)
- VERO 0.02
- QNRX 0.04
- MACD
- VERO -0.00
- QNRX 0.01
- Stochastic Oscillator
- VERO 12.62
- QNRX 17.24
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.